Combination therapy shows promise to treat a rare, catastrophic pediatric brain cancer
St. Jude Children's Research Hospital scientists identified a promising combination approach to treat a rare, but catastrophic pediatric brain cancer called atypical teratoid rhabdoid tumor (ATRT). Read more: https://www.news-medical.net/news/20251216/Combination-therapy-shows-promise-to-treat-a-rare-catastrophic-pediatric-brain-cancer.aspx
Dec 23, 2025
Researchers tackle rare, aggressive tumors in children
Recently, CureSearch for Children’s Cancer, a privately funded organization, recognized the work of John Prensner, M.D., Ph.D., a...
Jan 27, 2025
Researchers enhance natural killer cells to target pediatric brain cancer
In work published in Bioactive Materials , a research team led by Department of Chemistry and Biochemistry Professor Qing-Xiang "Amy"...
Aug 23, 2024
ATRT molecular groups: looking at the biology from the clinic
Atypical teratoid rhabdoid tumor (ATRT) is a rare brain tumor that predominantly occurs in young children. Scientists at St. Jude...
Mar 19, 2021
New potential treatment for aggressive brain cancer in children
Using state-of-the-art gene editing technology, scientists from Ann & Robert H. Lurie Children's Hospital of Chicago have discovered a...
Apr 12, 2017
Scientists find three subgroups in a children's brain cancer, identify druggable targets
Multi-institutional researchers investigating an incurable brain cancer in children have discovered three distinct subgroups of disease...
Dec 16, 2016

